You have 9 free searches left this month | to do more

selinexor

Selinexor is a drug used to treat Multiple Myeloma, Acute Myeloid Leukemia, Glioblastoma, and other conditions. Selinexor is being actively studied in 48 studies and prior, has been studied in 20.

Top SponsorsTop SitesTop Investigators
Karyopharm Therapeutics IncH. Lee Moffitt Cancer Center and Research InstituteBhavana Bhatnagar
H. Lee Moffitt Cancer Center and Research InstituteMemorial Sloan Kettering Cancer CenterErin Bertino
St. Jude Children's Research HospitalDana Farber Cancer InstituteDavid E Gerber
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • Soft Tissue Sarcoma
  • +3 more
  • Selinexor
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-03-29
Mar 29, 2021
J
Not yet recruiting
  • Multiple Myeloma
  • Selinexor
  • +4 more
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
2021-07-02
Jul 2, 2021
W
Not yet recruiting
  • Amyloid
  • +2 more
  • New York, New York
  • +1 more
2021-11-18
Nov 18, 2021
H
Active, not recruiting
  • Leukemia
  • +2 more
  • Selinexor
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021
N
Completed
  • Peripheral T-cell Lymphoma
  • Selinexor
  • ICE Chemotherapy
  • Singapore, Singapore
    National Cancer Centre Singapore
2021-04-27
Apr 27, 2021
U
Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Selinexor
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
2021-09-27
Sep 27, 2021
N
Recruiting
  • Gliosarcoma
  • +2 more
  • Selinexor
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-10-16
Oct 16, 2021
H
Active, not recruiting
  • Multiple Myeloma
  • Selinexor
  • +2 more
  • Tampa, Florida
  • +1 more
2021-08-03
Aug 3, 2021
G
Completed
  • Acute Myeloid Leukemia (Relapsed/Refractory)
  • Selinexor
  • +2 more
  • Frankfurt am Main, Hessen, Germany
  • +2 more
2021-08-01
Aug 1, 2021
W
Not yet recruiting
  • Myeloma Multiple
  • +2 more
  • Selinexor
  • +3 more
  • Aurora, Colorado
  • +2 more
2021-08-26
Aug 26, 2021
G
Recruiting
  • Sarcoma,Soft Tissue
  • Selinexor
  • Barcelona, Spain
  • +5 more
2021-11-16
Nov 16, 2021
K
Recruiting
  • Myelofibrosis
  • Selinexor
  • Physician's Choice Treatment
  • Pasadena, California
  • +2 more
2021-07-20
Jul 20, 2021
U
Active, not recruiting
  • Soft Tissue Sarcoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2020-09-24
Sep 24, 2020
H
Active, not recruiting
  • Multiple Myeloma
  • Selinexor
  • +4 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-18
Nov 18, 2021
M
Recruiting
  • Advanced Urothelial Carcinoma
  • +3 more
  • Pembrolizumab
  • Selinexor
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
2021-04-19
Apr 19, 2021
N
Recruiting
  • Advanced Refractory Solid Tumors
  • +2 more
  • Singapore, Singapore
    National University Hospital
2021-08-31
Aug 31, 2021
L
Not yet recruiting
  • Multiple Myeloma
  • Selinexor
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
2021-05-13
May 13, 2021
K
Terminated
  • Prostate Cancer
  • Selinexor
  • Houston, Texas
    M.D. Anderson Cancer Center
2021-01-07
Jan 7, 2021
H
Completed
  • Breast Cancer
  • Selinexor
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2020-09-09
Sep 9, 2020
T
Active, not recruiting
  • B-cell Lymphoma
  • selinexor
  • +6 more
  • Bruxelles, Belgium
  • +7 more
2021-07-23
Jul 23, 2021
K
Terminated
  • Glioblastoma
  • Glioma
  • Selinexor
  • Boston, Massachusetts
  • +5 more
2021-07-30
Jul 30, 2021